Highly Sensitive Acetylcholine Analysis – Cholinesterase Inhibitor Free
- No acetylcholinesterase inhibitor is required for the medial prefrontal cortex.
- The new improved enzymatic column provides increased sensitivity
- The reproducible sensitivity level of 5 fmol
- 18 minute run time with an internal standard, 13 minutes without internal standard.
- Also allows for the detection of Choline
Detection of acetylcholine (ACh) has historically been difficult for in-vivo monitoring via microdialysis because of the low levels present in the brain. A cholinesterase inhibitor has typically been added to the perfusate to overcome this, which increases the basal levels to an easily detectable range. The scientific community has accepted this procedure because of the hard nature of ACh detection, but not without controversy. However, artificially changing the physiological conditions changes the basal state and can cause confounding or misinterpreted results.
Eicom introduces a breakthrough technology coupling HPLC-ECD with a newly improved enzyme reactor, AC-ENZYM II 1.0 x 4.0 mm. This reactor has a seven times longer lifetime than our previous model reactor (AC-ENZYMPAK, 3.0 x 4.0 mm). The combination of this reactor with our unique mobile phase conditions reduces chromatography noise and consequently increased our sensitivity two-fold. Our conventional enzyme reactor had a 50% reduction in activity after one month of continuous mobile phase flow. The new AC-ENZYM II has only a 25% reduction of activity to ACh after 3 months of normal use without removal from the flow system.
The combination of the sensitive and stable HPLC-ECD system and the new enzyme reactor,
AC-ENZYM II allows for precise detection of basal acetylcholine levels well above the limits
of detection. This method reliably allows for a detection limit of 5 fmol in 18 minutes of
(see in the download file)
In-Vivo Microdialysis Study
Male Wistar rats (250-300g) were used in the following studies. Rats were surgically implanted with guide cannulae (Eicom CXG-6) in the striatum. Eight hours after guide cannula implantation, a microdialysis probe was slowly inserted (CX-I-6-03) and perfused with Ringer’s solution at 1.0 μl/min. The dialysate was collected into an injector loop and mixed via a 3-way joint (JY-33) with an internal standard (IS). The sample was then automatically injected into the HPLC-ECD for automated analysis with Eicom’s online autoinjector (EAS-20). The results are shown in figures 2 and 3.
Fig. 1 – Flow diagram of HPLC columns and detection Enzyme immobilized column (reactor) and the platinum working electrode can easily be used without chemical preparation such as enzyme modification of the working electrode.
See in the Download File
Fig. 2 – Standard chromatogram obtained from a 20 μl injection of a 10 nM standard. The Choline (Ch) peak appears prior to the IPHC peak at 8 min.
See in the Download File
Fig. 3 – ACh analysis obtained from a 20 μl striatum microdialysis sample. The ACh peak area corresponds to 10 fmol. This figure shows the basal condition following 3.5 hrs of aCSF perfusion without a cholinesterase inhibitor. The microdialysis probe used was Eicom CX-I-8-03, a 3 mm active membrane length.